| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/03/2015 | US8969514 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| 03/03/2015 | US8969513 Caspofungin analog and applications thereof |
| 03/03/2015 | US8969398 Methods of treating hepatic encephalopathy |
| 03/03/2015 | US8969385 Ocular formulations of norketotifen |
| 03/03/2015 | US8969361 Cyclopropanecarboxylate esters of purine analogues |
| 03/03/2015 | US8969357 Methods for treating HCV |
| 03/03/2015 | US8969331 Treatment of skin and mucosal superficial wounds using adrenergic receptor agonists |
| 03/03/2015 | US8969311 Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide |
| 03/03/2015 | US8969310 Potentiation of anticancer agents |
| 03/03/2015 | US8969309 Crystal of peptide substance as well as the preparation method and use thereof |
| 03/03/2015 | US8969308 Treatment of T-cell mediated diseases |
| 03/03/2015 | US8969307 Cyclosporin compositions |
| 03/03/2015 | US8969306 Cyclosporin compositions |
| 03/03/2015 | US8969305 Aqueous ophthalmic solution based on cyclosporin |
| 03/03/2015 | US8969304 Compositions and methods for the prevention of cancer in high risk patients |
| 03/03/2015 | US8969303 Tocotrienol esters |
| 03/03/2015 | US8969302 Low frequency glatiramer acetate therapy |
| 03/03/2015 | US8969301 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases |
| 03/03/2015 | US8969300 Na-K pump modulation |
| 03/03/2015 | US8969299 Therapeutic agents for regulating serum phosphorus |
| 03/03/2015 | US8969298 Liquid preparation of physiologically active peptide |
| 03/03/2015 | US8969297 Methods and compositions for the induction of hypothermia |
| 03/03/2015 | US8969296 TGFP-CAP peptide and its uses |
| 03/03/2015 | US8969295 Identifying and modulating molecular pathways that mediate nervous system plasticity |
| 03/03/2015 | US8969294 Glucagon/GLP-1 receptor co-agonists |
| 03/03/2015 | US8969293 Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 03/03/2015 | US8969292 High affinity leptins and leptin antagonists |
| 03/03/2015 | US8969291 Methods for decreasing leptin levels or activity for treating inflammation |
| 03/03/2015 | US8969289 Serum albumin binding molecules |
| 03/03/2015 | US8969288 Amide based glucagon and superfamily peptide prodrugs |
| 03/03/2015 | US8969287 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 03/03/2015 | US8969080 Remedy for the treatment of cardio-vascular diseases or disorders |
| 03/03/2015 | US8969077 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord |
| 03/03/2015 | US8968786 Formation of stable submicron peptide or protein particles by thin film freezing |
| 03/03/2015 | US8968782 Combination degradable and non-degradable matrices for active agent delivery |
| 03/03/2015 | US8968764 Nerve regeneration employing keratin biomaterials |
| 03/03/2015 | US8968760 Attachment of a biomaterial to tissue |
| 03/03/2015 | US8968748 GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| 03/03/2015 | US8968747 Injection paradigm for administration of botulinum toxins |
| 03/03/2015 | US8968745 Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 03/03/2015 | US8968734 Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies |
| 03/03/2015 | US8968732 Methods of treating pain using an IL-31 monoclonal antibody |
| 03/03/2015 | US8968731 Treatment of uveitis |
| 03/03/2015 | US8968728 Chimeric fusion proteins |
| 03/03/2015 | US8968727 Telomerase activity inhibiting peptide and manufacturing method and application thereof |
| 03/03/2015 | US8968726 Lactoferrin and angiogenin compositions and uses thereof |
| 03/03/2015 | US8968722 Milk-based nutritional compositions containing lactoferrin and uses thereof |
| 03/03/2015 | US8968720 Heat shock protein GP96 vaccination and methods of using same |
| 03/03/2015 | US8968716 In situ-forming hydrogel for tissue adhesives and biomedical use thereof |
| 03/03/2015 | US8968391 Systems and methods to reduce gel retraction |
| 02/26/2015 | WO2015027219A2 Apparatus and methods useful for dispensing one or more substances from a single container |
| 02/26/2015 | WO2015027173A1 Stable glucagon peptide formulations |
| 02/26/2015 | WO2015027082A1 Tgf-beta receptor type ii variants and uses thereof |
| 02/26/2015 | WO2015027056A1 NOVEL METHOD OF REDUCING ANTIGENIC DRIFT OR REASSORTMENT OF VIRUSES IN A HOST ANIMAL USING α- INTERFERON |
| 02/26/2015 | WO2015026939A1 Chemical inducers of fetal hemoglobin |
| 02/26/2015 | WO2015026831A1 Compositons and methods for the treatment of radiation exposure |
| 02/26/2015 | WO2015026494A2 Methods for treating tissue fibrosis |
| 02/26/2015 | WO2015026245A1 Beta-casein a2 and blood glucose levels |
| 02/26/2015 | WO2015025979A1 Method for producing microparticles |
| 02/26/2015 | WO2015025956A1 Pharmaceutical composition for treating myocardial damage, pharmaceutical composition for preventing myocardial damage, pharmaceutical composition for treating heart failure, pharmaceutical composition for preventing heart failure, method for treating or preventing myocardial damage or heart failure, mfg-e8, uses of mfg-e8, and method for screening compounds for treating or preventing myocardial damage or heart failure |
| 02/26/2015 | WO2015025323A1 Treatment of mood and stress related disorders |
| 02/26/2015 | WO2015025000A1 Pharmaceutical compositions comprising bortezomib |
| 02/26/2015 | WO2015024503A1 Engineering clostridia neurotoxins with elevated catalytic activity |
| 02/26/2015 | WO2015024450A1 Lhrh antagonist derivative and pharmaceutical use thereof |
| 02/26/2015 | WO2015024389A1 Vancomycin derivative, and preparation method and application thereof |
| 02/26/2015 | WO2015024148A1 Vaccine from cell factor mutant of heterogeneous animal |
| 02/26/2015 | US20150057605 Stable Glucagon Peptide Formulations |
| 02/26/2015 | US20150057233 Calcineurin inhibitors for use in the treatment of lesional vestibular disorders |
| 02/26/2015 | US20150057232 Anti-Inflammatory Composition for Modulating the Cell Response of Neutrophils and Eosinophils |
| 02/26/2015 | US20150057231 Use of Engrailed Proteins for Increasing Dopamine Synthesis by Dopaminergic Neurons |
| 02/26/2015 | US20150057229 Method of treating bone disorders using tsg-6 |
| 02/26/2015 | US20150057227 Compositions, devices and methods of use thereof for the treatment of cancers |
| 02/26/2015 | US20150057226 Method for treatment of labor arrest |
| 02/26/2015 | US20150057225 Method and Composition for Synchronizing Time of Insemination |
| 02/26/2015 | US20150057224 Methods for chronic pain management and treatment using hcg |
| 02/26/2015 | US20150057222 Methods of treating cartilage defects using a soluble morphogenic protein complex |
| 02/26/2015 | US20150057221 Prodrug comprising a drug linker conjugate |
| 02/26/2015 | US20150057219 Reversible pegylated drugs |
| 02/26/2015 | US20150057216 Angiotensins for treatment of fibrosis |
| 02/26/2015 | US20150056700 Bone morphogenic protein binding peptide |
| 02/26/2015 | US20150056300 Therapeutic nanoparticles with high molecular weight copolymers |
| 02/26/2015 | US20150056299 Food supplement to support brain function |
| 02/26/2015 | US20150056297 Nutraceutical combination for prevention and treatment of type 2 diabetes |
| 02/26/2015 | US20150056290 Microsphere compositions, preparation method and applications thereof |
| 02/26/2015 | US20150056285 Sustained release formulations using non-aqueous carriers |
| 02/26/2015 | US20150056281 Treatment of Multiple Sclerosis With Combination of Laquinimod and Interferon-Beta |
| 02/26/2015 | US20150056263 Implantable meshes for controlling the movement of fluids |
| 02/26/2015 | US20150056254 Method for manufacturing transdermally delivered hyaluronic acid-protein conjugate and transdermally delivered hyaluronic acid-protein conjugate manufactured using same |
| 02/26/2015 | US20150056253 Engineered nucleic acids and methods of use thereof |
| 02/26/2015 | US20150056246 Subunit vaccine delivery platform for robust humoral and cellular immune responses |
| 02/26/2015 | US20150056223 Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease |
| 02/26/2015 | US20150056218 P97 fragments with transfer activity |
| 02/26/2015 | US20150056217 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4 associated disorders |
| 02/26/2015 | US20150056204 Dr5 receptor agonist combinations |
| 02/26/2015 | US20150056181 Nanocarriers with multi-photon response elements |
| 02/26/2015 | US20150056179 New process for the production and purification of the collagenase enzyme from vibrio alginolyticus |
| 02/26/2015 | US20150056178 Modified beta-lactamases and methods and uses related thereto |
| 02/26/2015 | US20150056172 Methods and compositions using fgf-8 to enhance cardiac regeneration and attenuate adverse cardiac remodeling |
| 02/26/2015 | US20150056167 Peptides, derivatives and analogs thereof, and methods of using same |
| 02/26/2015 | US20150056166 Flavone derivatives and their use |